Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
NASA's make-or-break moon shot - 2Select Your Definitive Pizza Decision
- 3Help Your Insusceptibility: Good dieting and Way of life Tips
- 4From Educational Loans to Obligation Free: Independence from the rat race Accomplished
- 5Do-It-Yourself Home Style on a Careful spending plan: Imaginative Thoughts and Tasks
- Flu cases are spiking earlier than usual. What you need to know.
- Whale stranded off Germany for days is stuck again
- Burger King launches 'SpongeBob' menu ahead of film's release. A look at the Bikini Bottom-inspired meal, plus what taste testers are saying.
- Protester climbs on to balcony of Iranian embassy in London
- The Response to Self-improvement: Embracing a Development Outlook
- How to disinfect if the stomach bug hits your home
- Congolese rape survivors search in vain for medicine after USAID cuts
- 2025 Yachting Editors' Choice Awards: Yachts
- The 10 Most Significant Virtual Entertainment Missions
